CSF2 and diabetic ketoacidosis: This is the first report of successful use of a short course (5 days) of GM-CSF for refractory rhino-orbital cerebral mucormycosis in an adult patient after diabetic ketoacidosis, highlighting the therapeutic potential of this pragmatic approach.